The immune biological basis of severe fatigue after COVID-19 infection (IMMUNOFATIGUE)

• Conditions: COVID-19; severe fatigue; 10027665; 10024970

• Registration Number: NL-OMON56832
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 8 July 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 105

Inclusion Criteria

• Post COVID-19 diagnosis (based on positive PCR or multidisciplinary team
decision based on symptoms and CT or positive serology)
• Referred for outpatient follow-up
• Age >= 18 years
• Provided written informed consent

Exclusion Criteria

• Unable or not willing to provide written informed consent
• Unable to complete written questionnaires in Dutch
• Living in a nursing home because of a diagnosis of dementia
• Patients that visit the outpatient clinic in another hospital outside of the
region

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified